T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Terreno Realty
TRNO
$7.48B
| $420M | 0.05% |
7,537,213
+848,447
| +13% | +$55.8M |
|
327
Baker Hughes
BKR
$63.8B
| $419M | 0.05% |
14,519,450
-6,221,220
| -30% | -$210M |
|
328
PayPal
PYPL
$50.6B
| $417M | 0.05% |
5,974,221
-9,667,374
| -62% | -$839M |
|
329
Peloton Interactive
PTON
$2.38B
| $411M | 0.05% |
44,787,453
+3,818,380
| +9% | +$61.3M |
|
330
Cadence Design Systems
CDNS
$89B
| $410M | 0.05% |
2,733,627
-176,780
| -6% | -$26.7M |
|
331
VeriSign
VRSN
$25.6B
| $405M | 0.05% |
2,422,825
-84,551
| -3% | -$15.5M |
|
332
Bunge Global
BG
$21.5B
| $403M | 0.05% |
4,439,919
-2,315,423
| -34% | -$257M |
|
333
Constellation Brands
STZ
$22.9B
| $396M | 0.05% |
1,697,507
+45,493
| +3% | +$11.1M |
|
334
Trex
TREX
$5.05B
| $393M | 0.05% |
7,218,654
+80,597
| +1% | +$4.86M |
|
|
APLS
335
DELISTED
Apellis Pharmaceuticals
APLS
| $393M | 0.05% |
8,679,813
+794,974
| +10% | +$36.2M |
|
336
XP
XP
$7.98B
| $391M | 0.05% |
21,759,862
-4,644,127
| -18% | -$107M |
|
337
Element Solutions
ESI
$9.37B
| $389M | 0.05% |
21,844,504
+740,230
| +4% | +$15M |
|
338
Neurocrine Biosciences
NBIX
$15.9B
| $386M | 0.05% |
3,956,287
-332,483
| -8% | -$30.7M |
|
339
Kemper
KMPR
$1.56B
| $385M | 0.05% |
8,037,987
+719,256
| +10% | +$36M |
|
340
Popular Inc
BPOP
$11.2B
| $384M | 0.05% |
4,988,811
-286,543
| -5% | -$22.8M |
|
341
Apollo Global Management
APO
$81.9B
| $382M | 0.05% |
7,880,195
+5,912,758
| +301% | +$322M |
|
342
Rexford Industrial Realty
REXR
$8.11B
| $380M | 0.05% |
6,601,949
+1,422,052
| +27% | +$97.7M |
|
343
Manulife Financial
MFC
$72.6B
| $374M | 0.05% |
21,589,406
+174,580
| +0.8% | +$3.3M |
|
344
Airbnb
ABNB
$108B
| $370M | 0.05% |
4,155,190
+199,786
| +5% | +$26M |
|
345
Halliburton
HAL
$27.7B
| $365M | 0.05% |
11,629,366
-3,356,814
| -22% | -$125M |
|
346
Dentsply Sirona
XRAY
$2.27B
| $357M | 0.05% |
9,987,997
+905,001
| +10% | +$36.6M |
|
347
Vulcan Materials
VMC
$36.3B
| $353M | 0.04% |
2,481,334
+102,353
| +4% | +$16.9M |
|
|
CTXS
348
DELISTED
Citrix Systems Inc
CTXS
| $351M | 0.04% |
3,617,272
-2,949,609
| -45% | -$294M |
|
349
Cheniere Energy
LNG
$55.4B
| $339M | 0.04% |
2,545,865
+2,411,551
| +1,795% | +$328M |
|
350
Reliance Steel & Aluminium
RS
$21.8B
| $337M | 0.04% |
1,981,575
+258,662
| +15% | +$48.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.